Vijaya Diagnostic Centre Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹979.10
▼ -25.40 (-2.53%)
2026-03-02 00:00:00
Share Price BSE
₹978.85
▼ -24.85 (-2.48%)
2026-03-02 00:00:00
Track Vijaya Diagnostic Centre share price live with TickJournal's free stock screener. Analyze Vijaya Diagnostic Centre share price history trends and compare 52-week high low levels. Calculate VIJAYA stock fair value using fundamental analysis and view live share price charts. Determine Vijaya Diagnostic Centre share intrinsic value and compare it with current VIJAYA share price. Record your Vijaya Diagnostic Centre trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹13.95
Dividend Yield 0.20%
Debt to Equity 0.40
VIJAYA 52 Week High ₹1144.20
Vijaya Diagnostic Centre 52 Week Low ₹891.20
Operating Margin 39.00%
Profit Margin 19.55%
EBITDA ₹73.00
Net Income ₹35.00
Total Assets ₹1,274.00
Total Equity ₹799.00

Vijaya Diagnostic Centre Share Price History - Stock Screener Chart

Screen VIJAYA historical share price movements with interactive charts. Analyze price trends and patterns.

Vijaya Diagnostic Centre Company Profile - Fundamental Screener

Screen Vijaya Diagnostic Centre company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIJAYA shares.
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across...more
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
Chairperson/CEO Sura Surendranath Reddy
ISIN INE043W01024

Vijaya Diagnostic Centre Balance Sheet Screener

Screen VIJAYA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 1,274 983 853 714 541 482 301 234
Current Assets 307 211 276 270 239 186 138 103
Fixed Assets 865 742 524 371 268 272 151 119
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 312 250 241 178 138 150 40 33
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 799 660 547 470 359 274 211 161
Share Capital 10 10 10 10 5 5 5 5
Reserves & Surplus 786 647 535 458 355 270 204 155

Vijaya Diagnostic Centre Income Statement Screener - Profit & Revenue Analysis

Screen Vijaya Diagnostic Centre income statement and profit fundamentals. Analyze VIJAYA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vijaya Diagnostic Centre share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 179 195 208 210 159 160 188 174 126 127 146 138 119 107 124
Expenses 105 115 120 119 92 95 107 102 72 73 82 82 68 65 72
EBITDA 73 81 88 91 66 65 81 72 54 54 64 55 51 43 52
Operating Profit % 39.00% 39.00% 41.00% 42.00% 41.00% 39.00% 42.00% 40.00% 41.00% 40.00% 41.00% 38.00% 41.00% 38.00% 40.00%
Depreciation 19 21 22 24 16 17 17 18 11 13 14 15 15 14 16
Interest 7 8 8 9 6 6 7 7 6 6 6 6 4 5 5
Profit Before Tax 47 52 58 58 44 42 57 47 37 36 45 35 31 24 31
Tax 13 14 15 15 10 10 15 11 9 9 11 9 8 6 8
Net Profit 35 39 43 43 34 32 42 35 28 26 34 26 24 18 24
EPS 3.38 3.76 4.21 4.20 3.27 3.06 4.10 3.42 2.69 2.57 3.26 2.53 2.33 1.71 2.29

Vijaya Diagnostic Centre Cash Flow Screener - Liquidity Fundamentals

Screen VIJAYA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March
Operating Activities 225 183 165 158 130 106 91 62
Investing Activities -182 -141 -110 -123 -130 -31 -90 -98
Financing Activities -52 -45 -42 -31 -49 -30 -7 -8
Net Cash Flow -9 -2 13 4 -49 46 -7 -44

Vijaya Diagnostic Centre Shareholding Pattern Screener

See Vijaya Diagnostic Centre shareholding pattern with promoter, FII, and DII holdings. Check Vijaya Diagnostic Centre promoter holding and ownership changes for VIJAYA on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 53.05% 52.63% 52.60% 52.60% 54.06% 53.93% 53.91% 53.91%
FII Holding 19.36% 19.56% 18.27% 15.10% 20.09% 20.08% 18.14% 17.54%
DII Holding 23.72% 24.07% 25.34% 28.59% 20.80% 21.49% 23.46% 24.63%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 3.42% 3.24% 3.20% 3.14% 4.38% 3.98% 3.94% 3.43%
Other Holding 0.45% 0.50% 0.59% 0.57% 0.67% 0.52% 0.55% 0.49%
Shareholder Count 66,891 62,115 58,994 57,784 66,724 62,415 62,258 60,952

Vijaya Diagnostic Centre Share Dividend Screener - Share Yield Analysis

Check Vijaya Diagnostic Centre dividend history with payout and yield data. View Vijaya Diagnostic Centre dividend details including ex-dates and amounts for VIJAYA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹2.00 0.20%
2024-March ₹1.00 0.10%
2023-March ₹1.00 0.16%
2022-March ₹1.00 0.25%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Vijaya Diagnostic Centre Stock Index Membership

See which indices include Vijaya Diagnostic Centre stock. Check VIJAYA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.

Vijaya Diagnostic Centre Market Events Screener - Corporate Actions

Get Vijaya Diagnostic Centre corporate actions including splits, bonuses, and buybacks. Check Vijaya Diagnostic Centre stock events that may affect VIJAYA share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 3.68%
Dividend ₹ 1.00 /share 25.94%
Dividend ₹ 1.00 /share 3.49%
Annual General Meeting NA 15.76%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 2.58%
2025-11-25 2025-11-25 Merger - Demerger 22:1 0.00%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 3.04%
2025-08-29 2025-08-29 Dividend ₹ 2.00 /share -0.04%
2025-07-28 2025-07-28 Quarterly Result Announcement NA 2.38%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -2.35%
2025-04-25 2025-04-25 Extraordinary General Meeting NA 1.00%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -7.14%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 4.96%
2024-08-30 2024-08-30 Dividend ₹ 1.00 /share 33.84%

Vijaya Diagnostic Centre Competitors Screener - Peer Comparison

Screen VIJAYA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,455 44.20 2,555 11.28% 492 45.41
Vijaya Diagnostic Centre 10,319 63.39 700 23.06% 144 52.38
Metropolis Healthcare 9,866 57.85 1,346 10.64% 146 47.89
Thyrocare Technologies 6,265 46.76 702 20.80% 91 39.10
Nephrocare Health Services 5,958 85.34 770 33.97% 67 63.76
Krsnaa Diagnostics 2,061 25.79 743 16.70% 78 31.91
Suraksha Diagnostic 1,414 44.53 256 15.11% 31 41.23
One Global Service Provider 1,288 21.78 148 134.60% 19 49.03
3B BlackBio DX 1,160 21.53 112 28.72% 48 33.03
Sastasundar Ventures 901 30.64 1,171 -18.47% -134 39.51

Vijaya Diagnostic Centre Company Announcements - News Screener

Screen VIJAYA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-24 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 View
2026-02-22 Announcement under Regulation 30 (LODR)-Earnings Call Transcript View
2026-02-14 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-02-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2026-02-13 Appointment Of Mr. Ankit Shah As A Chief Financial Officer (CFO) Of The Company W.E.F. Feb 13 2026 View
2026-02-13 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) View
2026-02-13 Announcement under Regulation 30 (LODR)-Change in Directorate View
2026-02-13 Announcement under Regulation 30 (LODR)-Change in Management View
2026-02-13 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS View
2026-02-13 Announcement under Regulation 30 (LODR)-Investor Presentation View
2026-02-13 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2026-02-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On Feb 13 2026 View
2026-02-13 Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2025 View
2026-02-09 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-02-06 Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended December 31 2025. View
2026-01-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-08 Announcement under Regulation 30 (LODR)-Allotment View
2026-01-02 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-12-24 Closure of Trading Window View
2025-12-05 Cancellation Of Analyst / Institutional Investor Meeting Dated December 08 2025. View